Histidine derivatives as tridentate chelators for the fac-[MI(CO)3] (Re, 99mTc, 188Re) core: Synthesis, structural characterization, radiochemistry and stability

The development of new rhenium(I)- and technetium(I)–tricarbonyl complexes can lead to potentially useful radiopharmaceuticals. In this work, the synthesis of the neutral rhenium complex fac-[Re(NSO)(CO)3], Re-1, where NSO is the tridentate chelating agent 3-(1H-imidazol-4-yl)-2-(p-methoxy-benzylthio)propionic acid 1 was effected via reaction with (NEt4)2[ReBr3(CO)3] in the presence of NaHCO3. Complex Re-1 crystallized from methanol/water and its structure was established by IR, 1H and 13C NMR spectroscopies, ESI-MS analysis and X-ray crystallography. When the reaction took place in the absence of base, HPLC analysis revealed the presence of a second product (yield 7%) that was assigned by NMR and ESI analysis to be complex fac-[Re(NS)(CO)3Br] Re-2. At the tracer level, the analogous complexes fac-[99mTc(NSO)(CO)3], 99mTc-1 and fac-[188Re(NSO)(CO)3], 188Re-1, were synthesized and their radiochemical stability in physiological conditions was determined. Both tracer complexes 99mTc-1 and 188Re-1 are stable in solution as well as in the presence of strongly coordinating agents like histidine or cysteine.

The synthesis and characterization of neutral complexes of the formula fac-[M(NSO)(CO)3], where M = Re, Re-1 or 99mTc, 99mTc-1 or 188Re, 188Re-1 and NSO is a tridentate chelator 3-(1H-imidazol-4-yl)-2-(p-methoxybenzylthio)propionic acid 1, are presented. Both tracer complexes 99mTc-1 and 188Re-1 are stable in solution as well as in the presence of strongly coordinating agents like histidine or cysteine.Figure optionsDownload as PowerPoint slideHighlights
► fac-[99mTc/Re/188Re(NSO)(CO)3] complexes with a novel NSO chelator.
► High stability of 99mTc/188Re complexes in His and Cys challenge experiments.
► Highly potent NSO ligand easily prepared by histidine derivatization.
► Potentially useful system for development of new targeted radiopharmaceuticals.